395 related articles for article (PubMed ID: 38641651)
1. Multiparametric MRI for characterization of the tumour microenvironment.
Hoffmann E; Masthoff M; Kunz WG; Seidensticker M; Bobe S; Gerwing M; Berdel WE; Schliemann C; Faber C; Wildgruber M
Nat Rev Clin Oncol; 2024 Jun; 21(6):428-448. PubMed ID: 38641651
[TBL] [Abstract][Full Text] [Related]
2. Value of multiparametric magnetic resonance imaging for local staging of invasive urinary bladder tumours.
Huele EH; Veenboer PW; Wessels FJ; Jonges TN; Meijer RP
Urol Oncol; 2023 Jan; 41(1):49.e7-49.e12. PubMed ID: 36441069
[TBL] [Abstract][Full Text] [Related]
3. Detection and localisation of primary prostate cancer using
Kalapara AA; Nzenza T; Pan HYC; Ballok Z; Ramdave S; O'Sullivan R; Ryan A; Cherk M; Hofman MS; Konety BR; Lawrentschuk N; Bolton D; Murphy DG; Grummet JP; Frydenberg M
BJU Int; 2020 Jul; 126(1):83-90. PubMed ID: 31260602
[TBL] [Abstract][Full Text] [Related]
4. Photoacoustic imaging as a tool to probe the tumour microenvironment.
Brown E; Brunker J; Bohndiek SE
Dis Model Mech; 2019 Jul; 12(7):. PubMed ID: 31337635
[TBL] [Abstract][Full Text] [Related]
5. Biparametric MRI for Local Staging of Prostate Cancer: Current Status and Future Applications.
Dell'atti L
Anticancer Res; 2024 Feb; 44(2):463-470. PubMed ID: 38307562
[TBL] [Abstract][Full Text] [Related]
6. Head-to-Head Comparison of
Exterkate L; Hermsen R; Küsters-Vandevelde HVN; Prette JF; Baas DJH; Somford DM; van Basten JA
Eur Urol Oncol; 2023 Dec; 6(6):574-581. PubMed ID: 37230883
[TBL] [Abstract][Full Text] [Related]
7. Genomic Evaluation of Multiparametric Magnetic Resonance Imaging-visible and -nonvisible Lesions in Clinically Localised Prostate Cancer.
Parry MA; Srivastava S; Ali A; Cannistraci A; Antonello J; Barros-Silva JD; Ubertini V; Ramani V; Lau M; Shanks J; Nonaka D; Oliveira P; Hambrock T; Leong HS; Dhomen N; Miller C; Brady G; Dive C; Clarke NW; Marais R; Baena E
Eur Urol Oncol; 2019 Feb; 2(1):1-11. PubMed ID: 30929837
[TBL] [Abstract][Full Text] [Related]
8. Multimodal Molecular Imaging of the Tumour Microenvironment.
Foray C; Barca C; Backhaus P; Schelhaas S; Winkeler A; Viel T; Schäfers M; Grauer O; Jacobs AH; Zinnhardt B
Adv Exp Med Biol; 2020; 1225():71-87. PubMed ID: 32030648
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study.
Necchi A; Bandini M; Calareso G; Raggi D; Pederzoli F; Farè E; Colecchia M; Marandino L; Bianchi M; Gallina A; Colombo R; Fossati N; Gandaglia G; Capitanio U; Dehò F; Giannatempo P; Lucianò R; Salonia A; Madison R; Ali SM; Chung JH; Ross JS; Briganti A; Montorsi F; De Cobelli F; Messina A
Eur Urol; 2020 May; 77(5):636-643. PubMed ID: 31882281
[TBL] [Abstract][Full Text] [Related]
10. Multi-parametric MRI (mpMRI) for treatment response assessment of radiation therapy.
Wang C; Padgett KR; Su MY; Mellon EA; Maziero D; Chang Z
Med Phys; 2022 Apr; 49(4):2794-2819. PubMed ID: 34374098
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric MRI and radiomics in prostate cancer: a review.
Sun Y; Reynolds HM; Parameswaran B; Wraith D; Finnegan ME; Williams S; Haworth A
Australas Phys Eng Sci Med; 2019 Mar; 42(1):3-25. PubMed ID: 30762223
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice.
Zawaideh JP; Sala E; Shaida N; Koo B; Warren AY; Carmisciano L; Saeb-Parsy K; Gnanapragasam VJ; Kastner C; Barrett T
Eur Radiol; 2020 Jul; 30(7):4039-4049. PubMed ID: 32166495
[TBL] [Abstract][Full Text] [Related]
13. Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review.
Stabile A; Giganti F; Kasivisvanathan V; Giannarini G; Moore CM; Padhani AR; Panebianco V; Rosenkrantz AB; Salomon G; Turkbey B; Villeirs G; Barentsz JO
Eur Urol Oncol; 2020 Apr; 3(2):145-167. PubMed ID: 32192942
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric Magnetic Resonance Imaging of Penile Cancer: A Pictorial Review.
Switlyk MD; Hopland A; Reitan E; Sivanesan S; Brennhovd B; Axcrona U; Hole KH
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001583
[TBL] [Abstract][Full Text] [Related]
15. Biparametric versus Multiparametric Magnetic Resonance Imaging for Assessing Muscle Invasion in Bladder Urothelial Carcinoma with Variant Histology Using the Vesical Imaging-Reporting and Data System.
Arita Y; Kwee TC; Woo S; Shigeta K; Ishii R; Okawara N; Edo H; Waseda Y; Vargas HA
Eur Urol Focus; 2024 Jan; 10(1):131-138. PubMed ID: 37633790
[TBL] [Abstract][Full Text] [Related]
16. Do patients who undergo multiparametric MRI for prostate cancer benefit from additional staging imaging? Results from a statewide collaborative.
Eyrich NW; Tosoian JJ; Drobish J; Montie JE; Qi J; Kim T; Noyes SL; Moriarity AK; Lane BR;
Urol Oncol; 2020 Jul; 38(7):636.e13-636.e19. PubMed ID: 32067844
[TBL] [Abstract][Full Text] [Related]
17. Staging of bladder cancer with multiparametric MRI.
Juri H; Narumi Y; Panebianco V; Osuga K
Br J Radiol; 2020 Aug; 93(1112):20200116. PubMed ID: 32516554
[TBL] [Abstract][Full Text] [Related]
18. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 1: Acquisition.
Engels RRM; Israël B; Padhani AR; Barentsz JO
Eur Urol; 2020 Apr; 77(4):457-468. PubMed ID: 31582290
[TBL] [Abstract][Full Text] [Related]
19. Voxel-level biological optimisation of prostate IMRT using patient-specific tumour location and clonogen density derived from mpMRI.
Her EJ; Haworth A; Reynolds HM; Sun Y; Kennedy A; Panettieri V; Bangert M; Williams S; Ebert MA
Radiat Oncol; 2020 Jul; 15(1):172. PubMed ID: 32660504
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Accuracy of Single-plane Biparametric and Multiparametric Magnetic Resonance Imaging in Prostate Cancer: A Randomized Noninferiority Trial in Biopsy-naïve Men.
Russo F; Mazzetti S; Regge D; Ambrosini I; Giannini V; Manfredi M; De Luca S; Bollito E; Porpiglia F
Eur Urol Oncol; 2021 Dec; 4(6):855-862. PubMed ID: 33893066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
